These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6198509)

  • 1. Pulmonary fate of [3H]bleomycin A2 in mice.
    Lazo JS; Pham ET
    J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
    Harrison JH; Hoyt DG; Lazo JS
    Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing the Sh ble bleomycin resistance gene are protected against bleomycin-induced pulmonary fibrosis.
    Weinbach J; Camus A; Barra J; Dumont P; Julian M; Cros S; Babinet C; Tiraby G
    Cancer Res; 1996 Dec; 56(24):5659-65. PubMed ID: 8971172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, subcellular distribution, and covalent binding of [3H]bleomycin in hamsters after intratracheal administration.
    Giri SN
    Exp Mol Pathol; 1986 Oct; 45(2):207-20. PubMed ID: 2429861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
    Ekimoto H; Takahashi K; Matsuda A; Umezawa H
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo circumvention of human colon carcinoma resistance to bleomycin.
    Jani JP; Mistry JS; Morris G; Davies P; Lazo JS; Sebti SM
    Cancer Res; 1992 May; 52(10):2931-7. PubMed ID: 1374681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of surfactant protein SP-A, SP-B, and SP-C mRNA in lungs of rats with bleomycin-induced pulmonary fibrosis].
    Song M; He B; Qiu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):420-2. PubMed ID: 11326882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the pulmonary toxin, bleomycin.
    Tom WM; Montgomery MR
    Drug Metab Dispos; 1979; 7(2):90-3. PubMed ID: 89025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression of messenger RNA coding for procollagen and tumour necrosis factor-alpha in lungs undergoing bleomycin-induced pulmonary fibrosis].
    Cai H; Zheng P; Dai L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):753-5. PubMed ID: 11480082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.